NASDAQ:BLRX

BioLineRx Ltd. Stock Insider Trading

NASDAQ Stock Exchange > Healthcare > Biotechnology

$0.105

+0.0035 (+3.45%)

At Close: Jan 21, 2025

BioLineRx Ltd. Stock Insider Power

Based on the 0 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 0 and sold 0 BLRX shares in the last 0 trades.

Historical Insider Trades

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

ABOUT BIOLINERX LTD.

BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in pat...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
H HYLS $41.55	0.289%	Jan 15
ROIC $17.41	0.230%	Jan 15
V VGSH $58.23	0.0515%	Jan 15
F FALN $26.87	0.447%	Jan 15
F FTSM $59.87	0.0668%	Jan 15

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by